Even ‘low-risk’ patients need drugs after STEMI, say cardiologists
A growing cohort of patients without traditional CV risk factors are at high risk of death post-MI, research suggests.
Tag: Pharmacology
Thalidomide survivors paid more than $17m
A national apology from the Federal Government is also in the works, says a health department official.
Self-medication with psychedelics rising, survey suggests
Australians are among the world's highest users of illicit substances such as LSD and psilocybin.
New drug for ANCA-associated vasculitis superior to prednisone?
Trial data could herald a 'previously unthinkable' era of achieving remission without glucocorticoids, a leading rheumatologist says.
Why it’s still too soon to legalise psychedelics for mental illness
While the public focus remains on COVID-19 vaccines, the TGA continues to evaluate a range of proposals around the provision of medical treatments in Australia.…
Trial douses hope aspirin can ease depression in the elderly
New data from ASPREE research point to its possible adverse effects.
Medicines Australia and AMA in stoush over ‘critical’ shortages
The pharmaceuticals peak body says supply chain comments could trigger panic buying.
Why psychedelics are returning to psychiatry
But are these experimental treatments little more than drug-assisted psychotherapy?
Even low doses of steroids up CVD risk: study
UK research shows significant dose-response estimates for daily doses of <5.0mg for all immune-mediated diseases across all CV outcomes.
Cannabidiol use ‘does not impair driving’
But medicinal cannabis containing THC is another matter and there’s concern the study doses were too low.
